Treatment Duration of Bactrim for Infected Cysts
For infected cysts, Bactrim (trimethoprim-sulfamethoxazole) should be administered for 7-10 days at a dosage of one double-strength tablet (160 mg trimethoprim/800 mg sulfamethoxazole) orally twice daily. 1
Dosing Considerations
- The standard adult dose for skin and soft tissue infections, including infected cysts, is 1 double-strength tablet (160 mg trimethoprim/800 mg sulfamethoxazole) twice daily 1
- Treatment duration of 7-10 days is recommended for adequate eradication of the infection in soft tissue infections including cysts 1
- Clinical improvement should be evident within 48-72 hours of initiating therapy; if no improvement is seen, consider possible resistance or need for drainage 1
Efficacy and Resistance Considerations
- Bactrim efficacy is significantly reduced when treating infections caused by resistant organisms (84% cure rate with susceptible organisms vs. 41% with resistant organisms) 2, 3
- Local resistance patterns should be considered before prescribing Bactrim; it should only be used empirically when local resistance rates are below 20% 3
- For infected cysts, obtaining cultures before treatment is recommended whenever possible to guide appropriate antibiotic selection 3
Special Considerations for Cyst Infections
- Trimethoprim can accumulate in cyst fluid, exceeding serum levels by up to eightfold, particularly in gradient cysts, making it potentially effective for cyst infections 4, 5
- Sulfamethoxazole penetrates cysts to a lesser extent, with concentrations ranging from 10-70% of serum levels 4
- Prolonged therapy may be necessary to ensure therapeutic success in cyst infections 5
Alternative Treatment Options
- If Bactrim is not effective or contraindicated, alternative antibiotics include:
Monitoring and Follow-up
- Complete the full course of antibiotics even if symptoms improve rapidly 1
- If fluctuance is present, incision and drainage should be performed in addition to antimicrobial therapy 1
- For recurrent or chronic infections, urine culture and susceptibility testing should be performed before initiating therapy 3